Ginwa Enterprise Group Inc (600080) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.019x

Based on the latest financial reports, Ginwa Enterprise Group Inc (600080) has a cash flow conversion efficiency ratio of 0.019x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥29.81 Million ≈ $4.36 Million USD) by net assets (CN¥1.58 Billion ≈ $231.66 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 600080 equity financing ratio to measure how much of total assets are equity-financed.

Ginwa Enterprise Group Inc - Cash Flow Conversion Efficiency Trend (1998–2025)

This chart illustrates how Ginwa Enterprise Group Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Ginwa Enterprise Group Inc (600080) cash flow quality to evaluate the quality of earnings relative to operating cash generation.

Ginwa Enterprise Group Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Ginwa Enterprise Group Inc ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Beijing Bohui Science & Technology Co Ltd
SHG:688004
-0.017x
Zhangjiagang Haiguo New Energy Equipment Manufacturing Co. Ltd.
SHE:301063
N/A
Praemium Ltd
AU:PPS
0.056x
Eaton Vance National Municipal Opportunities Closed Fund
NYSE:EOT
0.020x
Eledon Pharmaceuticals Inc
NASDAQ:ELDN
-0.103x
Eagle Point Income Company Inc
NYSE:EIC
0.022x
Calamos LongShort Equity & Dynamic Income Trust
NASDAQ:CPZ
0.125x
Putnam Managed Municipal Income Closed Fund
NYSE:PMM
0.036x

Annual Cash Flow Conversion Efficiency for Ginwa Enterprise Group Inc (1998–2025)

The table below shows the annual cash flow conversion efficiency of Ginwa Enterprise Group Inc from 1998 to 2025. For the full company profile with market capitalisation and key ratios, see 600080 market cap overview.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥1.56 Billion
≈ $228.04 Million
CN¥24.77 Million
≈ $3.62 Million
0.016x +128.23%
2024-12-31 CN¥1.56 Billion
≈ $228.20 Million
CN¥10.86 Million
≈ $1.59 Million
0.007x -81.16%
2023-12-31 CN¥1.64 Billion
≈ $239.75 Million
CN¥60.55 Million
≈ $8.86 Million
0.037x +18.34%
2022-12-31 CN¥1.68 Billion
≈ $246.39 Million
CN¥52.58 Million
≈ $7.69 Million
0.031x +69.04%
2021-12-31 CN¥1.66 Billion
≈ $242.36 Million
CN¥30.59 Million
≈ $4.48 Million
0.018x -31.70%
2020-12-31 CN¥1.72 Billion
≈ $251.89 Million
CN¥46.56 Million
≈ $6.81 Million
0.027x -58.36%
2019-12-31 CN¥1.72 Billion
≈ $251.06 Million
CN¥111.45 Million
≈ $16.31 Million
0.065x +294.35%
2018-12-31 CN¥1.77 Billion
≈ $259.22 Million
CN¥29.18 Million
≈ $4.27 Million
0.016x -57.02%
2017-12-31 CN¥1.12 Billion
≈ $163.66 Million
CN¥42.87 Million
≈ $6.27 Million
0.038x -1.25%
2016-12-31 CN¥1.07 Billion
≈ $157.13 Million
CN¥41.68 Million
≈ $6.10 Million
0.039x +33.85%
2015-12-31 CN¥1.05 Billion
≈ $153.06 Million
CN¥30.33 Million
≈ $4.44 Million
0.029x -13.83%
2014-12-31 CN¥1.02 Billion
≈ $149.29 Million
CN¥34.33 Million
≈ $5.02 Million
0.034x -23.57%
2013-12-31 CN¥998.35 Million
≈ $146.09 Million
CN¥43.96 Million
≈ $6.43 Million
0.044x +132.20%
2012-12-31 CN¥962.22 Million
≈ $140.80 Million
CN¥18.25 Million
≈ $2.67 Million
0.019x -80.86%
2011-12-31 CN¥918.45 Million
≈ $134.40 Million
CN¥91.02 Million
≈ $13.32 Million
0.099x +76.26%
2010-12-31 CN¥724.97 Million
≈ $106.09 Million
CN¥40.76 Million
≈ $5.96 Million
0.056x +3.91%
2009-12-31 CN¥691.57 Million
≈ $101.20 Million
CN¥37.42 Million
≈ $5.48 Million
0.054x -69.61%
2008-12-31 CN¥696.22 Million
≈ $101.88 Million
CN¥123.96 Million
≈ $18.14 Million
0.178x +1452.87%
2007-12-31 CN¥747.13 Million
≈ $109.33 Million
CN¥-9.83 Million
≈ $-1.44 Million
-0.013x -228.44%
2006-12-31 CN¥702.59 Million
≈ $102.81 Million
CN¥-2.82 Million
≈ $-411.98K
-0.004x +54.64%
2005-12-31 CN¥781.05 Million
≈ $114.29 Million
CN¥-6.90 Million
≈ $-1.01 Million
-0.009x -109.93%
2004-12-31 CN¥881.06 Million
≈ $128.93 Million
CN¥78.36 Million
≈ $11.47 Million
0.089x -0.45%
2003-12-31 CN¥869.84 Million
≈ $127.28 Million
CN¥77.72 Million
≈ $11.37 Million
0.089x +32.72%
2002-12-31 CN¥850.75 Million
≈ $124.49 Million
CN¥57.27 Million
≈ $8.38 Million
0.067x -30.49%
2001-12-31 CN¥829.75 Million
≈ $121.42 Million
CN¥80.36 Million
≈ $11.76 Million
0.097x -20.01%
2000-12-31 CN¥789.96 Million
≈ $115.60 Million
CN¥95.64 Million
≈ $14.00 Million
0.121x -2.80%
1999-12-31 CN¥480.99 Million
≈ $70.38 Million
CN¥59.91 Million
≈ $8.77 Million
0.125x -2.69%
1998-12-31 CN¥401.15 Million
≈ $58.70 Million
CN¥51.35 Million
≈ $7.51 Million
0.128x --

About Ginwa Enterprise Group Inc

SHG:600080 China Drug Manufacturers - Specialty & Generic
Market Cap
$267.10 Million
CN¥1.83 Billion CNY
Market Cap Rank
#15397 Global
#4538 in China
Share Price
CN¥4.89
Change (1 day)
-0.41%
52-Week Range
CN¥4.41 - CN¥9.16
All Time High
CN¥14.41
About

Ginwa Enterprise (Group) Inc. researches, develops, produces, markets, and sells traditional Chinese medicines, biological drugs, and chemical drugs primarily in China. The company offers a range of orthopaedics, immunity, children, and general medicines in various dosage forms, including tablets, capsules, granules, powders, mixtures, oral solutions, syrups, and external solutions. It is also in… Read more